» Articles » PMID: 34661655

Characterization of Streptomyces Sp. LS462 with High Productivity of Echinomycin, a Potent Antituberculosis and Synergistic Antifungal Antibiotic

Overview
Specialty Biotechnology
Date 2021 Oct 18
PMID 34661655
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

A biologically active microbial strain, designated as "LS462," was isolated from a soil sample collected from Yaoli Virgin Forest of Jiangxi Province, China. The strain was able to produce a high yield of echinomycin (172 mg/l) even under nonoptimized culture conditions and is proposed to serve as a promising source of echinomycin. In this study, echinomycin exhibited strong anti-Mycobacterium tuberculosis H37Rv activity and synergistic antifungal effect with a greatly reduced dosage of posaconazole on Candida albicans SC5314. The strain belongs to the genus Streptomyces according to its morphological and 16S rDNA phylogenetic analysis. The 16S rDNA was found to have the highest sequence identity with Streptomyces fuscichromogenes (99.37% similarity). Extensive nuclear magnetic resonance and mass spectroscopic data were used to determine the structure of echinomycin. The strain S. fuscichromogenes has not been previously reported to produce echinomycin. Strain LS462 may be exploited as a new potential source for the commercial production of echinomycin. Also, this work is the first to report the new synergistic antifungal activity of echinomycin and further study of the synergistic mechanism will be helpful to guide the development of antifungal agents.

Citing Articles

EmbB and EmbC regulate the sensitivity of to echinomycin.

He J, Gao Y, Wang J, Hameed H, Wang S, Fang C mLife. 2024; 3(3):459-470.

PMID: 39359678 PMC: 11442130. DOI: 10.1002/mlf2.12139.


Microbial pigments: Learning from Himalayan perspective to industrial applications.

Kumar S, Kumar V, Ambika A, Nag D, Kumar V, Darnal S J Ind Microbiol Biotechnol. 2022; .

PMID: 35933162 PMC: 9559291. DOI: 10.1093/jimb/kuac017.


The UvrA-like protein Ecm16 requires ATPase activity to render resistance against echinomycin.

Erlandson A, Gade P, Menikpurage I, Kim C, Mera P Mol Microbiol. 2022; 117(6):1434-1446.

PMID: 35534931 PMC: 9328131. DOI: 10.1111/mmi.14918.


Unique Cyclized Thiolopyrrolones from the Marine-Derived sp. BTBU20218885.

Song F, Hu J, Zhang X, Xu W, Yang J, Li S Mar Drugs. 2022; 20(3).

PMID: 35323513 PMC: 8953990. DOI: 10.3390/md20030214.

References
1.
Taylor S, Metch B, Balcerzak S, HANSON K . Phase II trial of echinomycin in advanced soft tissue sarcomas. A Southwest Oncology Group study. Invest New Drugs. 1990; 8(4):381-3. DOI: 10.1007/BF00198595. View

2.
Zhuo Y, Zhang W, Chen D, Gao H, Tao J, Liu M . Reverse biological engineering of hrdB to enhance the production of avermectins in an industrial strain of Streptomyces avermitilis. Proc Natl Acad Sci U S A. 2010; 107(25):11250-4. PMC: 2895102. DOI: 10.1073/pnas.1006085107. View

3.
Singh V, Nand A, Chen C, Li Z, Li S, Wang S . Echinomycin, a potential binder of FKBP12, shows minor effect on calcineurin activity. J Biomol Screen. 2014; 19(9):1275-81. DOI: 10.1177/1087057114544742. View

4.
Saitou N, Nei M . The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol. 1987; 4(4):406-25. DOI: 10.1093/oxfordjournals.molbev.a040454. View

5.
Schilsky R, Faraggi D, Korzun A, Vogelzang N, Ellerton J, Wood W . Phase II study of echinomycin in patients with advanced breast cancer: a report of Cancer and Leukemia Group B protocol 8641. Invest New Drugs. 1991; 9(3):269-72. DOI: 10.1007/BF00176982. View